Some things you should consider before using marijuana in Oregon:
ORS § 475.035 (2005)
475.035. Authority to control schedule; rules.
(1) In arriving at any decision on changes in or
addition to
classification when changes or additions are proposed by the federal
Drug Enforcement Administration or by any other reliable source, the
State Board of Pharmacy shall review the scientific knowledge available
regarding the substance, its pharmacological effects, patterns of use
and misuse, and potential consequences of abuse, and consider the
judgment of individuals with training and experience with the substance.
(2) Whenever the board determines that a change in or an addition to
the schedule of a controlled substance is justified, the board by
rule may order the change and fix the effective date thereof.
(3) If a substance is an ingredient of a controlled substance, the
ingredient shall be considered to be in the same schedule as that
controlled substance. Substances which are precursors of the
ingredient shall not be subject to control solely because they are
precursors of the ingredient. The use of the term "precursor" in
this subsection does not control and is not controlled by the use of
the term "precursor" in ORS 475.840 to 475.980.
(4) The board shall administer ORS 475.005 to 475.285 and 475.840 to
475.980 in accordance with ORS chapter 183.
(5) Authority to control under this section does not extend to
tobacco or to alcoholic beverages as defined in ORS 471.001.
Because Or. Rev. Stat. § 475.035 antedates the Federal Controlled
Substances Act, 21 USC §§ 811 to 812, Or. Rev. Stat. § 475.005(6)
and Or. Rev. Stat. § 475.035 show a legislative policy to apply
different criteria from those of the federal act when classifying
controlled substances; Oregon has not chosen to include medical use
as a factor. State v. Eells, 72 Or. App. 492, 696 P.2d 564 (1985),
review denied by 299 Ore. 313, 702 P.2d 1110 (1985).
Although Or. Rev. Stat. § 475.005(6) states that a controlled
substance is defined by reference to the schedules under the Federal
Controlled Substances Act, 21 USC §§ 811 to 812, the statute does
not adopt the federal criteria, as Oregon has its own standards for
amendment of the schedule, as set out in Or. Rev. Stat. § 475.035.
State v. Eells, 72 Or. App. 492, 696 P.2d 564 (1985), review denied
by 299 Ore. 313, 702 P.2d 1110 (1985).
http://arcweb.sos.state.or.us/rules/OARS_800/OAR_855/855_080.html
855-080-0020
Schedules
Pursuant to ORS 475.005(6) those drugs and their immediate
precursors classified in Schedules I through V under the Federal
Controlled Substances Act, 21 U.S.C. Sections 811 to 812 and as
amended by the Board pursuant to ORS 457.035 are the controlled
substances for purposes of regulation and control under the Act.
Those schedules are set out in OAR 855-080-0021 through
855-080-0026.
[Publications: Publications referenced are available from the
agency.]
Stat. Auth.: ORS 475 & 689
Stats. Implemented:
Hist.: 1PB 6-1978(Temp), f. & ef. 7-1-78; 1PB 8-1978, f. & ef.
10-17-78; 1PB 6-1982, f. & ef. 8-6-82; 1PB 2-1984, f. & ef. 3-7-84;
1PB 4-1984(Temp), f. & ef. 9-17-84; 1PB 1-1985, f. & ef. 2-27-85;
1PB 2-1985, f. & ef. 7-24-85; 1PB 4-1985, f. & ef. 12-2-85; 1PB
2-1986, f. & ef. 7-10-86; PB 4-1987, f. & ef. 3-30-87; PB 5-1991, f.
& cert. ef. 9-19-91
855-080-0021
Schedule I
(1) Schedule I consists of the drugs and other substances, by
whatever official, common, usual, chemical, or brand name
designated, listed in 21CFR part 1308.11, and unless specifically
excepted or unless listed in another schedule, any quantity of the
following substances, including their isomers, esters, ethers,
salts, and salts of isomers, esters, and ethers, whenever the
existence of such isomers, esters, ethers, and salts is possible
within the specific chemical designation:
(a) Benzylfentanyl;
(b) Thenylfentanyl;
(c) N-Benzylpiperazine (BZP);
(d) Triflouromethylphenyl) piperazine (TFMPP);
(e) 1,4-butanediol.
(2) Exceptions. The following are exceptions to subsection (1) of
this rule:
(a) 1, 4-butanediol and gamma-butyrolactone when in the possession
of a person for the purpose of its sale to a legitimate manufacturer
of industrial products and the person is in compliance with the Drug
Enforcement Administration requirements for List I Chemicals.
(b) 1,4-butanediol and gamma-butyrolactone when in the possession of
a person for the purpose of the legitimate manufacture of industrial
products.
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 475.035 & 475.940
Hist.: PB 4-1987, f. & ef. 3-30-87; PB 8-1987, f. & ef. 9-30-87; PB
10-1987, f. & ef. 12-8-87; PB 15-1989, f. & cert. ef. 12-26-89; PB
9-1990, f. & cert. ef. 12-5-90; PB 5-1991, f. & cert. ef. 9-19-91;
PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92); PB 1-1994,
f. & cert. ef. 2-2-94; PB 1-1996, f. & cert. ef. 4-5-96; PB 1-1997,
f. & cert. ef. 9-22-97; BP 4-2000, f. & cert. ef. 2-16-00; BP
9-2000, f. & cert. ef. 6-29-00; BP 2-2002(Temp), f. & cert. ef.
2-4-02 thru 7-31-02; BP 3-2002(Temp), f. & cert. ef. 3-1-02 thru
8-23-02; BP 4-2002, f. 6-27-02, cert. ef. 7-1-02; BP 5-2002, f. &
cert. ef. 11-14-02; BP 1-2003, f. & cert. ef. 1-14-03; BP 1-2007, f.
& cert. ef. 6-29-07
855-080-0022
Schedule II
Schedule II consists of the drugs and other substances by whatever
official, common, usual, chemical, or brand name designated, listed
in 21 CFR part 1308.12.
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 475.035
Hist.: PB 4-1987, f. & ef. 3-30-87; PB 8-1987, f. & ef. 9-30-87; PB
10-1987, f. & ef. 12-8-87; PB 15-1989, f. & cert. ef. 12-26-89; PB
9-1990, f. & cert. ef. 12-5-90; PB 5-1991, f. & cert. ef. 9-19-91;
PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92); PB 1-1994,
f. & cert. ef. 2-2-94; PB 1-1996, f. & cert. ef. 4-5-96; PB 1-1997,
f. & cert. ef. 9-22-97; BP 3-1999(Temp), f. & cert. ef. 8-9-99 thru
1-17-00; BP 4-2000, f. & cert. ef. 2-16-00; BP 4-2006, f. 6-9-06,
cert. ef. 7-1-06; BP 1-2007, f. & cert. ef. 6-29-07
855-080-0023
Schedule III
Schedule III consists of the drugs and other substances by whatever
official, common, usual, chemical, or brand name designated, listed
in 21 CFR part 1308.13; and
(1) Products containing pseudoephedrine or the salts of
pseudoephedrine as an active ingredient.
(2) Products containing ephedrine or the salts of ephedrine as an
active ingredient.
(3) Products containing phenylpropanolamine or the salts of
phenylpropanolamine as an active ingredient.
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 475.035
Hist.: PB 4-1987, f. & ef. 3-30-87; PB 11-1989, f. & cert. ef.
7-20-89; PB 5-1991, f. & cert. ef. 9-19-91; PB 1-1992, f. & cert.
ef.
1-31-92 (and corrected 2-7-92); BP 3-1999(Temp), f. & cert. ef.
8-9-99 thru 1-17-00; BP 4-2000, f. & cert. ef. 2-16-00; BP 9-2000,
f. & cert. ef. 6-29-00; BP 4-2006, f. 6-9-06, cert. ef. 7-1-06; BP
1-2007, f. & cert. ef. 6-29-07
855-080-0024
Schedule IV
Schedule IV consists of:
(1) The drugs and other substances, by whatever official, common,
usual, chemical, or brand name designated, listed in 21 CFR part
1308.14, unless specifically excepted or listed in another schedule:
and
(2) Products containing carisoprodol or the salts of carisoprodol as
an active ingredient.
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 475.035
Hist.: PB 4-1987, f. & ef. 3-30-87; PB 5-1991, f. & cert. ef.
9-19-91; PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92);
PB 1-1995, f. & cert. ef. 4-27-95; PB 1-1996, f. & cert. ef. 4-5-96;
PB 1-1997, f. & cert. ef. 9-22-97; BP 4-2000, f. & cert. ef.
2-16-00; BP 9-2000, f. & cert. ef. 6-29-00; BP 1-2007, f. & cert.
ef.
6-29-07
855-080-0026
Schedule V
Schedule V consists of the drugs and other substances, by whatever
official, common, usual, chemical, or brand name designated, listed
in 21 CFR part 1308.15.
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 475.035
Hist.: PB 4-1987, f. & ef. 3-30-87; PB 5-1991, f. & cert. ef.
9-19-91; BP 1-2007, f. & cert. ef. 6-29-07
855-080-0028
Excluded Substances
The following drugs and their generic equivalents are excepted from
the schedules in OAR 855-080-0021 through 855-080-0026:
(1) Benzedrex inhaler (Propylhexedrine).
(2) Estratest.
(3) Estratest HS.
(4) Estradiol Cypionate Injection.
(5) Estradiol Valerate Injection.
(6) Premarin with Methyltestosterone.
(7) Vicks -- Vapor inhaler (Levmetamfetamine).
Stat. Auth.: ORS 689.205
Stats. Implemented: ORS 689.155
Hist.: 1PB 6-1978(Temp), f. & ef. 7-1-78; 1PB 8-1978, f. & ef.
10-17-78; 1PB 6-1982, f. & ef. 8-6-82; PB 4-1987, f. & ef. 3-30-87;
Renumbered from 855-080-0025; PB 5-1991, f. & cert. ef. 9-19-91; PB
1-1995, f. & cert. ef. 4-27-95; BP 4-2006, f. 6-9-06, cert. ef.
7-1-06; BP 6-2006(Temp), f. & cert. ef. 8-25-06 thru 1-31-07; BP
8-2006, f. & cert. ef. 12-19-06